نتایج جستجو برای: cognitive enhancers

تعداد نتایج: 255486  

Journal: :Pharmacology Biochemistry and Behavior 2011

Journal: :JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH 2015

Journal: :Archives of General Psychiatry 2004

2013
Cynthia Forlini Wayne Hall Bruce Maxwell Simon M. Outram Peter B. Reiner Dimitris Repantis Maartje Schermer Eric Racine

An increasing number of opinions and commentaries are being written about the possible benefits and risks of so-called ‘cognitive enhancers’ [1], a term that usually refers to technologies that purportedly augment cognitive performance or modulate mood and behaviour [2]. These discussions have focused on both existing pharmaceuticals, such as prescription medications, and new drugs and technolo...

Journal: :Clinical Pharmacology & Therapeutics 2016

Journal: :Pharmacology Biochemistry and Behavior 2011

2012
Andrea C Tricco Sondra vanderVaart Charlene Soobiah Erin Lillie Laure Perrier Maggie H Chen Brenda Hemmelgarn Sumit R Majumdar Sharon E Straus

BACKGROUND Approximately 35 million people world-wide have Alzheimer's disease and this is projected to nearly double by 2030. Cognitive enhancers, including cholinesterase inhibitors (for example, donepezil, galantamine and rivastigmine) and memantine (N-methyl-D-aspartic acid (NMDA) receptor antagonist) have been approved for the treatment of Alzheimer's disease in many countries. Our objecti...

Journal: :Medical Sciences Forum 2021

The use of nutraceuticals as cognitive enhancers is on the rise and may be especially problematic in polymedicated older patients. potential interaction these products with drugs commonly prescribed to this age group evaluated work, by identification mutual targets (enzymes, transporters receptors).

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید